Cargando…

Virtual Screening and Molecular Design of Potential SARS-COV-2 Inhibitors

According to recent studies, the main M(pro) protease of the SARS-CoV-2 virus, which is the most important target in the development of promising drugs for the treatment of COVID-19, is evolutionarily conservative and has not undergone significant changes compared with the main M(pro) protease of th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tinkov, O. V., Grigorev, V. Yu., Grigoreva, L. D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pleiades Publishing 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207500/ http://dx.doi.org/10.3103/S0027131421020127

Ejemplares similares

Prediction of an Organic Compound’s Biotransformation Time: A Study Using Avermectins
por: Tinkov, O. V., et al.
Publicado: (2021)

Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors
por: Jiménez-Alberto, Alicia, et al.
Publicado: (2020)

Virtual screening of phytochemical compounds as potential inhibitors against SARS-CoV-2 infection
por: Kothandan, Ram, et al.
Publicado: (2021)

Virtual screening of molecular databases for potential inhibitors of the NSP16/NSP10 methyltransferase from SARS-CoV-2
por: Gomes, João Pedro Agra, et al.
Publicado: (2022)

In search of SARS CoV-2 replication inhibitors: Virtual screening, molecular dynamics simulations and ADMET analysis
por: Nagar, Prinsa R., et al.
Publicado: (2021)

Discovery of genistein derivatives as potential SARS-CoV-2 main protease inhibitors by virtual screening, molecular dynamics simulations and ADMET analysis
por: Liu, Jiawei, et al.
Publicado: (2022)

Commercial SARS-CoV-2 Targeted, Protease Inhibitor Focused and Protein–Protein Interaction Inhibitor Focused Molecular Libraries for Virtual Screening and Drug Design
por: Kralj, Sebastjan, et al.
Publicado: (2021)

Virtual Screening of Repurposed Drugs as Potential Spike Protein Inhibitors of Different SARS-CoV-2 Variants: Molecular Docking Study
por: Eweas, Ahmad F., et al.
Publicado: (2022)

Identification of novel TMPRSS2 inhibitors against SARS-CoV-2 infection: a structure-based virtual screening and molecular dynamics study
por: Manandhar, Suman, et al.
Publicado: (2022)

Identification, virtual screening and molecular dynamic analysis of novel TMPRSS2 inhibitors from natural compound database as potential entry-blocking agents in SARS-CoV-2 therapy
por: Manandhar, Suman, et al.
Publicado: (2022)

Repurposing approved drugs as potential inhibitors of 3CL-protease of SARS-CoV-2: Virtual screening and structure based drug design
por: Meyer-Almes, Franz-Josef
Publicado: (2020)

Design of SARS-CoV-2 Mpro, PLpro dual-target inhibitors based on deep reinforcement learning and virtual screening
por: Zhang, Li-chuan, et al.
Publicado: (2022)

Virtual Screening of Artemisia annua Phytochemicals as Potential Inhibitors of SARS-CoV-2 Main Protease Enzyme
por: Miandad, Khalid, et al.
Publicado: (2022)

Identification of Potential Inhibitors of 3CL Protease of SARS-CoV-2 From ZINC Database by Molecular Docking-Based Virtual Screening
por: Abdusalam, Ashraf Ahmed Ali, et al.
Publicado: (2020)

Structure-Based Virtual Screening and Identification of Potential Inhibitors of SARS-CoV-2 S-RBD and ACE2 Interaction
por: Xiong, Jiacheng, et al.
Publicado: (2021)

Virtual screening of immunomodulatory medicinal compounds as promising anti-SARS-COV-2 inhibitors
por: Salman, Saad, et al.
Publicado: (2020)

High Throughput Virtual Screening to Discover Inhibitors of the Main Protease of the Coronavirus SARS-CoV-2
por: Olubiyi, Olujide O., et al.
Publicado: (2020)

Targeting the SARS-CoV-2 spike glycoprotein prefusion conformation: virtual screening and molecular dynamics simulations applied to the identification of potential fusion inhibitors
por: Romeo, Alice, et al.
Publicado: (2020)

Identification of potential inhibitors of omicron variant of SARS-Cov-2 RBD based virtual screening, MD simulation, and DFT
por: Lü, Xudong, et al.
Publicado: (2022)

Discovery of potential ALK inhibitors by virtual screening approach
por: Kumar, Anish, et al.
Publicado: (2016)

Screening potential FDA-approved inhibitors of the SARS-CoV-2 major protease 3CL(pro) through high-throughput virtual screening and molecular dynamics simulation
por: Liu, Wen-Shan, et al.
Publicado: (2021)

A machine learning regression model for the screening and design of potential SARS-CoV-2 protease inhibitors
por: Janairo, Gabriela Ilona B., et al.
Publicado: (2021)

Virtual screening and molecular dynamics simulation study of plant protease inhibitors against SARS-CoV-2 envelope protein
por: Kirar, Manisha, et al.
Publicado: (2022)

Systematic virtual screening in search of SARS CoV-2 inhibitors against spike glycoprotein: pharmacophore screening, molecular docking, ADMET analysis and MD simulations
por: Dhameliya, Tejas M., et al.
Publicado: (2022)

Structure-Based Virtual Screening and Molecular Dynamics Simulation to Identify Potential SARS-CoV-2 Spike Receptor Inhibitors from Natural Compound Database
por: Sarkar, Arkadeep, et al.
Publicado: (2021)

Structure-Based Virtual Screening and Biochemical Validation to Discover a Potential Inhibitor of the SARS-CoV-2 Main Protease
por: Gupta, Akshita, et al.
Publicado: (2020)

Virtual high throughput screening: Potential inhibitors for SARS-CoV-2 PL(PRO) and 3CL(PRO) proteases
por: Jade, Dhananjay, et al.
Publicado: (2021)

Identification of known drugs as potential SARS-CoV-2 Mpro inhibitors using ligand- and structure-based virtual screening
por: Federico, Leonardo Bruno, et al.
Publicado: (2021)

Virtual high-throughput screening: Potential inhibitors targeting aminopeptidase N (CD13) and PIKfyve for SARS-CoV-2
por: Ruan, Zijing, et al.
Publicado: (2023)

Finding potential inhibitors for Main protease (Mpro) of SARS-CoV-2 through virtual screening and MD simulation studies
por: Ahamed, N. Anis, et al.
Publicado: (2023)

Consensus virtual screening of dark chemical matter and food chemicals uncover potential inhibitors of SARS-CoV-2 main protease
por: Santibáñez-Morán, Marisa G., et al.
Publicado: (2020)

Computational molecular docking and virtual screening revealed promising SARS-CoV-2 drugs
por: Hosseini, Maryam, et al.
Publicado: (2021)

Virtual Screening and Molecular Design Based on Hierarchical Qsar Technology
por: Kuz’min, Victor E., et al.
Publicado: (2009)

Identification of a novel inhibitor of SARS-CoV-2 3CL-PRO through virtual screening and molecular dynamics simulation
por: Bepari, Asim Kumar, et al.
Publicado: (2021)

Structure-based virtual screening and molecular dynamics simulation studies to discover new SARS-CoV-2 main protease inhibitors
por: Ibezim, A., et al.
Publicado: (2021)

Identification of natural compounds as SARS-CoV-2 entry inhibitors by molecular docking-based virtual screening with bio-layer interferometry
por: Zhang, Dingqi, et al.
Publicado: (2021)

Multi-stage structure-based virtual screening approach towards identification of potential SARS-CoV-2 NSP13 helicase inhibitors
por: El Hassab, Mahmoud A., et al.
Publicado: (2022)

Fenoterol and dobutamine as SARS-CoV-2 main protease inhibitors: A virtual screening study
por: Bolelli, Kayhan, et al.
Publicado: (2021)

Selection of SARS-CoV-2 main protease inhibitor using structure-based virtual screening
por: Hakami, Abdulrahim R, et al.
Publicado: (2021)

Design, synthesis and in silico screening of benzoxazole–thiazolidinone hybrids as potential inhibitors of SARS-CoV-2 proteases
por: Krishna Cheerala, Vijay Sai, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_59ipp7k2a7m6ss8r3k60ipnsrm